You can buy or sell Illumina and other stocks, options, ETFs, and crypto commission-free!
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Read More The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Next Generation Sequencing Sample Preparation Market Size, Share & Trends Analysis Report by Workflow, by Application, by End-Use And Segment Forecasts, 2019 - 2025NEW YORK, Dec. 9, 2019 /PRNewswire/ -- Next Generation Sequencing Sample Preparation Market Size, Share & Trends Analysis Report by Workflow (Automated Library
Expected Jan 28, After Hours